In recent years, in order to further accelerate the pace of development and development of the new product, the company strengthened its cooperation with internationally renowned pharmaceutical companies and research institutions。 In 2012, it signed the technology authorization and cooperation agreement with Taiwan Taijing Biological Technology Co。, Ltd。 and Taijing Biomedical Research and Development (Beijing) Co。, Ltd。 and obtained the exclusive patent license of the 1。1 class innovation medicine fluorine-free quinolone "nemonoxacin" within the territory of China。 Its oral 。。。


At present, Zhejiang Medicine Co. Ltd. is specialized in the large-scale production of fat-soluble vitamins, quasi-vitamins, quino-lone antibiotics, anti-drug-resistant antibiot- ics and other products. Its output of vitamin E is the largest domestically, and the 2nd largest globally; the output of Vancomycin hydrochloride accounts for more than 40% of the global production.

新疆喜乐彩 陕西快乐十分 贵州11选5 9号彩票官网 重庆快乐十分 甘肃快3 广西快乐十分 青海快3 9号彩票网 陕西快乐十分